Citation Tools
PDFResearch ethics
On the personal utility of Alzheimer’s disease-related biomarker testing in the research context
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- On the personal utility of Alzheimer’s disease-related biomarker testing in the research context
Other content recommended for you
- Exploring cognitive and biological correlates of sleep quality and their potential links with Alzheimer’s disease (ALFASleep project): protocol for an observational study
- Personal utility in genomic testing: is there such a thing?
- Retinal imaging in Alzheimer’s disease
- What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France
- New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist
- Moral motivation regarding dementia risk testing among affected persons in Germany and Israel
- Plasma biomarkers for Alzheimer’s disease: a field-test in a memory clinic
- Remote data collection speech analysis and prediction of the identification of Alzheimer’s disease biomarkers in people at risk for Alzheimer’s disease dementia: the Speech on the Phone Assessment (SPeAk) prospective observational study protocol
- Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study
- Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study